Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice Carla Boquimpani; Fernanda Salles Seguro; Gustavo Henrique Romani Magalhães; Ingrid Luise Soares Pinto; Israel Bendit; Jaisson André Pagnoncelli Bortolini; Katia Borgia Barbosa Pagnano; Renato Centrone; Vaneuza Funke;

Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring Fernanda Salles Seguro; Carolina Maria Pinto Domingues Carvalho Silva; Carla Maria Boquimpani de Moura; Monika Conchon; Laura Fogliatto; Vaneuza Araujo Moreira Funke; André Abdo; Ariane Vieira Scarlatelli Macedo; Marilia Harumi Higushi dos Santos; José Francisco Kerr Saraiva;

Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report Renato Centrone; Marcelo Bellesso; Debora Bonito; Daniela Dias; Rodrigo Santucci; Milton Aranha; Adelson Alves;